
BLUEJAY DIAGNOSTICS INC
BJDXNASDAQTrading Snapshot
- Day Range
- $1.06 โ $1.09
- 52-Week Range
- $0.83 โ $16.68
- Volume
- $3.00B
- Avg Volume
- $3.84B
- Shares Outstanding
- 1.0M
- Next Earnings
- Sep 7, 2026
Fundamentals Snapshot
- Annual Revenue
- $131,202
- Last Q Revenue
- $34,732
- P/E Ratio
- โ
- P/S Ratio
- โ
- EPS (TTM)
- $-53.96
- Dividend Yield
- โ
Why Investors Own BJDX
- โHigh-growth profile โ revenue up +45.1% YoY with expanding US Equity exposure.
- โHealthy economics โ 55% gross margin and 6% free-cash-flow margin.
- โNew products and segments could unlock additional revenue streams.
Execution delays, intensifying competition, and valuation compression if growth decelerates.
Financial Trends
About BLUEJAY DIAGNOSTICS INC
Bluejay Diagnostics, Inc. functions as a company specializing in medical diagnostic solutions. A key offering is their Symphony platform, an advanced technological system. This platform is composed of the Symphony analyzer, which skillfully orchestrates the processing of whole blood, the isolation of biomarkers, and the preparation of immunoassays using non-contact centrifugal force. It also includes the Symphony Cartridge, which comes pre-loaded with essential reagents and components. The company additionally provides the ALLEREYE diagnostic test, a convenient, on-site device for quickly identifying allergic conjunctivitis. Bluejay Diagnostics is also progressing with the development of Symphony IL-6 tests, intended for monitoring disease advancement in critical care environments. Furthermore, they are actively creating additional diagnostic tests for their Symphony platform, such as those aimed at detecting myocardial infarction (heart attack) and congestive heart failure. Bluejay Diagnostics, Inc. was founded in 2015 and is headquartered in Acton, Massachusetts.
Otter Score Breakdown
โAnalyst Ratings
โLatest News & Updates

Which stocks are moving on Wednesday?
Curious to know what's happening on the US markets one hour before the close of the markets on Wednesday? Join us as we explore the top gainers and losers in today's session.

Discover the most active stocks in Wednesday's session.
Curious about the most active stocks on Wednesday? Find out which stocks are dominating the market action!

Wednesday's session: top gainers and losers
Stay up-to-date with the latest market trends in the middle of the day on Wednesday. Explore the top gainers and losers during today's session in our detailed report.

Gapping stocks in Wednesday's session
The market is filled with gapping stocks in Wednesday's session. Let's discover which stocks are showing gap-ups and gap-downs.

12 Health Care Stocks Moving In Wednesday's Intraday Session
Gainers Zhengye Biotechnology (NASDAQ:ZYBT) stock increased by 107.0% to $2.65 during Wednesday's regular session. The company's market cap stands at $60.6 million. Bluejay Diagnostics (NASDAQ:BJDX) shares

Discover the top movers in Wednesday's pre-market session.
Before the opening bell on Wednesday, let's take a glimpse of the US markets and explore the top gainers and losers in today's pre-market session.